These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 8418158
21. Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines? Pier GB. Hum Vaccin; 2007; 3(2):39-40; author reply 41. PubMed ID: 17268204 [No Abstract] [Full Text] [Related]
22. Exotoxin A-PLGA nanoconjugate vaccine against Pseudomonas aeruginosa infection: protectivity in murine model. Safari Zanjani L, Shapouri R, Dezfulian M, Mahdavi M, Shafiee Ardestani M. World J Microbiol Biotechnol; 2019 Jun 11; 35(6):94. PubMed ID: 31187291 [Abstract] [Full Text] [Related]
23. Recombinant protein composed of Pseudomonas exotoxin A, outer membrane proteins I and F as vaccine against P. aeruginosa infection. Chen TY, Shang HF, Chen TL, Lin CP, Hui CF, Hwang J. Appl Microbiol Biotechnol; 1999 Oct 11; 52(4):524-33. PubMed ID: 10570800 [Abstract] [Full Text] [Related]
25. Comparative immunochemistry of two fragments from domains Ib and III of Pseudomonas aeruginosa exotoxin A. Rutault K, Vacheron MJ, Guinand M, Michel G. Infect Immun; 1993 Dec 11; 61(12):5417-20. PubMed ID: 8225617 [Abstract] [Full Text] [Related]
26. [Study of protective properties of recombinant atoxic form of exotoxin A and recombinant outer membrane protein F of Pseudomonas aeruginosa]. Mikhaĭlova NA, Vertiev IuV, Kaloshin AA, Isakov MA. Zh Mikrobiol Epidemiol Immunobiol; 2010 Dec 11; (2):39-44. PubMed ID: 20464999 [Abstract] [Full Text] [Related]
31. The role of proteases and exotoxin A in the pathogenicity of Pseudomonas aeruginosa infections. Wretlind B, Pavlovskis OR. Scand J Infect Dis Suppl; 1981 Dec 11; 29():13-9. PubMed ID: 6797058 [Abstract] [Full Text] [Related]
32. Broad-spectra human monoclonal antibodies that protect mice infected with Pseudomonas aeruginosa. Noguchi H, Yokota S, Ohtsuka H, Kohzuki T, Terashima M, Irie K. Antibiot Chemother (1971); 1991 Dec 11; 44():172-84. PubMed ID: 1724892 [No Abstract] [Full Text] [Related]
35. Use of exotoxin A to inhibit protein synthesis. Saelinger CB. Methods Enzymol; 1988 Dec 11; 165():226-31. PubMed ID: 3148096 [No Abstract] [Full Text] [Related]
36. The role of exotoxin A in pseudomonas disease and immunity. Pollack M. Rev Infect Dis; 1983 Dec 11; 5 Suppl 5():S979-84. PubMed ID: 6419320 [Abstract] [Full Text] [Related]
37. Identification of a small epitope in domain Ib of Pseudomonas aeruginosa exotoxin A that elicits enzyme-neutralizing antibodies. Rutault K, Coin D, Vacheron MJ, Guinand M, Wallach J, Michel G. FEMS Microbiol Immunol; 1992 Jul 11; 4(5):267-72. PubMed ID: 1381199 [Abstract] [Full Text] [Related]
38. A human hybrid hybridoma producing a bispecific monoclonal antibody that can target tumor cells for attack by Pseudomonas aeruginosa exotoxin A. Honda S, Ichimori Y, Iwasa S. Cytotechnology; 1990 Jul 11; 4(1):59-68. PubMed ID: 1369279 [Abstract] [Full Text] [Related]
39. A macromolecular structure produced by Pseudomonas aeruginosa is recognized by antibody to exotoxin A. Klinger KW, Shuster CW. Infect Immun; 1984 Mar 11; 43(3):912-9. PubMed ID: 6421741 [Abstract] [Full Text] [Related]
40. Contribution of exotoxin A of Pseudomonas aeruginosa in acute and chronic experimental renal infection. Sharma S, Kaur R, Yadav V, Harjai K, Joshi K. Jpn J Infect Dis; 2004 Jun 11; 57(3):119-20. PubMed ID: 15218223 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]